Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

Many U.S. Hospitals Mark Up Prices 1,000%

Sharon Begley  |  June 9, 2015

NEW YORK (Reuters)—Even the astronomical price markups that consumers regularly pay for, say, wine in restaurants pale beside those in some U.S. hospitals: The price for procedures is often 10 times the cost, according to a study published Monday in the journal Health Affairs. Of the 50 hospitals with the highest markups, 49 are for-profit,…

Filed under:Facility Tagged with:Centers for Medicare & Medicaid Services (CMS)costsHealth Insurancehospital

Ethics Forum: Terminating Hospital Consulting Services

Colin C. Edgerton, MD  |  April 1, 2015

Ethical considerations for rheumatologists in terminating consultative services to a community hospital

Filed under:EthicsPractice SupportProfessional Topics Tagged with:communityEthicshospitalpatient carerheumatologyservices

Selling a Rheumatology Practice to a Hospital or Health System

Steven M. Harris, Esq.  |  November 2, 2014

Negotiating points, key business decisions to consider when transferring ownership

Filed under:FacilityLegal UpdatesPractice SupportProfessional Topics Tagged with:HarrishospitalLegalphysician practicePractice Managementrheumatologist

Backlog Slows Medicare Appeals Process for Hospitals, Physicians

Richard Quinn  |  July 11, 2014

Recovery Audit Program brings in record number of appeals, clogs system

Filed under:Billing/CodingPractice Support Tagged with:claimslawsuitMedicareRecovery Audit Contractor

Hospitalists Gain Insight on Signs, Symptoms of Infection Among Inpatients on Biologic Drugs

Richard Quinn  |  June 6, 2014

Rheumatologist at Society of Hospital Medicine conference provides treatment recommendations for hospital patients with rheumatic disease

Filed under:Practice Support Tagged with:biologic drugsInfectioninpatientrheumatology

Shingles, Chickenpox Hospitalizations Higher for Patients on Anti-TNF Drugs

By Sue Pondrom  |  December 22, 2010

More research needed to clarify risks and benefits of VZV vaccination

Filed under:Research Rheum Tagged with:LiteratureResearchtumor necrosis factorvaricella zoster virus

Positive Week 12 Results for Rosnilimab in Patients with RA

Michele B. Kaufman, PharmD, BCGP  |  June 18, 2025

Early study results demonstrate that rosnilimab may be safe and effective for patients with rheumatoid arthritis, reducing the signs and symptoms of RA by week 12 and achieving important primary and secondary study end points.

Filed under:Biologics/DMARDsConditionsDrug UpdatesRheumatoid Arthritis Tagged with:Rheumatoid Arthritis (RA)rosnilimab

Biosimilar Update: 2025 Brings More FDA Approvals & Interchangeability

Michele B. Kaufman, PharmD, BCGP  |  June 18, 2025

Here is a brief recap of the latest FDA-approved biosimilar agents, highlighting their reference products and interchangeability.

Filed under:Biologics/DMARDsDrug Updates Tagged with:adalimumabBiosimilarsdenosumabFDA approvalinterchangeabilityU.S. Food and Drug Administration (FDA)

FDA Approves Upadacitinib for GCA

Michele B. Kaufman, PharmD, BCGP  |  June 16, 2025

Supported by data in patients with new-onset and relapsing giant cell arteritis (GCA), the FDA approved upadacitinib for the treatment of adults with GCA.

Filed under:Biologics/DMARDsConditionsDrug UpdatesVasculitis Tagged with:FDA approvalGCAgiant cell arteritis (GCA)U.S. Food and Drug Administration (FDA)upadacitinib

Summer 2025’s Awards, Appointments & Announcements in the World of Rheumatology

Gretchen Henkel  |  June 8, 2025

Sharad Lakhanpal, MBBS, MD, Receives India’s Highest Honor for Overseas Indians In early January, Sharad Lakhanpal, MBBS, MD, MACR, FACP, a rheumatologist at Rheumatology Associates in Dallas and past president of the ACR, was one of only three Indian-Americans to receive the 2025 Pravasi Bharatiya Samman Award (PBSA). The award is conferred every two years…

Filed under:AwardsCareer Tagged with:Dr. Christopher GoodnowDr. David NemazeeDr. Sharad LakhanpalLouise Vetter

  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 323
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences